Phase
Condition
N/ATreatment
Value-manipulation
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Has seizure activity which is deemed non-responsive to standard pharmacologicalintervention(s), as determined by treating Neurologist and established clinicalpractices
Has elected to receive clinically indicated intracranial EEG (electrocorticography (ECoG), stereoelectroencephalography (SEEG)) and/or temporal responsiveneurostimulation (RNS) for medication-refractory epilepsy outside of this researchstudy, as determined by treating clinician(s) and per current clinical practice
Capacity to provide written informed consent
Language proficiency in English or Spanish
Willing and able to comply with all study-related procedures
Exclusion
Exclusion Criteria:
History of psychosis, such as in the context of depressive or manic episode.
Active suicidal ideation with intent, suicide attempt within the last six months, orother serious suicide risk
Inability to provide informed consent or reliably participate in study assessments,as per the Montreal Cognitive Assessment (MOCA; score < 26) or in the opinion of theevaluating neuropsychologist.
Individuals unwilling or unable to undergo electrode implantation procedures
Medical contraindications to neurosurgery or for general anesthesia, neurosurgery,or an MRI scan (required for electrode implantation)
Neurological disorder other than epilepsy or other significant brain pathology, ifcontraindicated in the opinion of implanting neurosurgeon.
Women who are pregnant
Study Design
Connect with a study center
Mount Sinai West
New York, New York 10024
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.